AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Kawasumi Laboratories, Incorporated
  3. Financials
  4. Cash and cash equivalents

Kawasumi Laboratories, Incorporated【JP:E02310】

Market cap
P/E ratio
SummaryFinancialsDividendsHistoryWorkforce
Period EndCash and cash equivalents (Million JPY)YoY (%)
Mar 31, 202020,597+11.30%
Mar 31, 201918,506+11.03%
Mar 31, 201816,668+8.45%
Mar 31, 201715,370+1.51%
Mar 31, 201615,142+8.97%
Mar 31, 201513,895+42.76%
Mar 31, 20149,733+6.38%
Mar 31, 20139,149

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)